CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients

Clinical trial NCT04364737 · COMPLETED

Trial details

NCT number: NCT04364737
Sponsor: NYU Langone Health
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Coronavirus Coronavirus Infection

Start date: 2020-04-17
Primary completion: 2021-03-29
Enrollment: 941

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.